Accord Healthcare recall: Levothyroxine Sodium Tablets
Accord Healthcare, Inc. is recalling Levothyroxine Sodium Tablets because of the wrong strength – N/A. The U.S. Food and Drug Administration published the recall on September 2, 2026; it began on August 6, 2026. Distributed nationwide.
Serious Class II means the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.

Share
| Product | Levothyroxine Sodium Tablets |
| Brand | Accord Healthcare |
| Company | Accord Healthcare, Inc. |
| Type | Drugs |
| Classification | Class II |
| Recall date | August 6, 2026 |
| Published by FDA | September 2, 2026 |
| Quantity | N/A |
| Recall ID | 99584 |
Recalled products (12)
- Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-447-17.
- FDA recall number
- D-0775-2026
- Codes, lots and dates
- Lot #: D2401927, D2401833, Exp. Date 08/31/2026; D2402551, D2402552, Exp. Date 11/30/2026; D2500220, Exp. Date 12/31/2026; D2500223, Exp. Date 01/31/2027.
- Quantity
- N/A
- Classification
- Class II
- Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-448-17.
- FDA recall number
- D-0776-2026
- Codes, lots and dates
- Lot #: D2401834, D2401982, Exp. Date 08/31/2026; D2402584, D2402585, D2402586, D2402588, D2402587, D2402589, Exp Date. 11/30/2026.
- Quantity
- N/A
- Classification
- Class II
- Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-449-17.
- FDA recall number
- D-0777-2026
- Codes, lots and dates
- Lot #: D2402016, D2402017, Exp. Date 08/31/2026
- Quantity
- N/A
- Classification
- Class II
- Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-17.
- FDA recall number
- D-0778-2026
- Codes, lots and dates
- Lot #: D2401813, D2401814, Exp. Date 08/31/2026; D2500200, D2500219, Exp. Date 12/31/2026.
- Quantity
- N/A
- Classification
- Class II
- Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count bottles (NDC 16729-451-15) and b) 1000-count bottles, (NDC 16729-451-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.
- FDA recall number
- D-0779-2026
- Codes, lots and dates
- a) Lot #: D2402186, Exp. Date 09/30/2026. b) Lot #: D2402019, Exp. Date 08/31/2026; D2402094, Exp. Date 09/30/2026; D2500022, D2500023, D2500021, Exp. Date 12/31/2026.
- Quantity
- N/A
- Classification
- Class II
- Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-452-17.
- FDA recall number
- D-0780-2026
- Codes, lots and dates
- Lot #: D2402443, D2402444, D2402445, Exp. Date 10/31/2026.
- Quantity
- N/A
- Classification
- Class II
- Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-453-17.
- FDA recall number
- D-0781-2026
- Codes, lots and dates
- Lot #: D2401983, Exp. Date 08/31/2026; D2402640, D2402641, Exp. Date 11/30/2026; D2500224, Exp. Date 01/31/2027.
- Quantity
- N/A
- Classification
- Class II
- Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count bottles (NDC 16729-454-15) b) 1000-count bottles (NDC 16729-454-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.
- FDA recall number
- D-0782-2026
- Codes, lots and dates
- a) Lot # D2402125, D2402126, D2402127, Exp. Date 09/30/2026. b) Lot #: D2402523, D2402524, Exp. Date 11/30/2026.
- Quantity
- N/A
- Classification
- Class II
- Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-455-17.
- FDA recall number
- D-0783-2026
- Codes, lots and dates
- Lot #: D2402195, D2402196, D2402197, Exp. Date 09/30/2026.
- Quantity
- N/A
- Classification
- Class II
- Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-456-15), and b) 1000-count bottles (NDC 16729-456-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.
- FDA recall number
- D-0784-2026
- Codes, lots and dates
- a) Lot #: D2402642, Exp. Date 11/30/2026 b) Lot #: D2401832, Exp. Date 08/31/2026; D2402525, D2402527, D2402526, D2402644, D2402643, Exp. Date 11/30/2026.
- Quantity
- N/A
- Classification
- Class II
- Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729-457-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.
- FDA recall number
- D-0785-2026
- Codes, lots and dates
- a) Lot # D2402430, D2402431, Exp Date: 10/31/2026. b) Lot #: D2402432, Exp. Date 10/31/2026; D2500180, Exp. Date 12/31/2026.
- Quantity
- N/A
- Classification
- Class II
- Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-458-15.
- FDA recall number
- D-0786-2026
- Codes, lots and dates
- Lot #: D2402337, Exp. Date 10/31/2026.
- Quantity
- N/A
- Classification
- Class II
Identifiers and details
- FDA event ID
- 99584
- Initiated
- Voluntary: Firm initiated
- Status
- Ongoing
- Firm location
- Raleigh, NC, United States
Why it was recalled
The problem: the wrong strength.
The reason the FDA lists: “Subpotent Drug”
Where it was sold
Nationwide. Distribution as the FDA records it: “Nationwide within the United States”
What to do
Compare the recall numbers, lot numbers and expiration dates with what you have. Do not stop a prescribed medicine or device without talking to your pharmacist or doctor – they can arrange a replacement from an unaffected lot.
Official notice: FDA Enforcement Report record (event 99584, openFDA) – the same recall numbers can be searched in the FDA Enforcement Report.
Other drug recalls
| Date | Recall | Problem | Agency |
|---|---|---|---|
| Oct 7, 2026 | Failed Dissolution Specifications: below specification Serious | FDA Class II | |
| Oct 7, 2026 | Crystallization Serious | FDA Class II | |
| Oct 7, 2026 | Failed dissolution specifications. Serious | FDA Class II | |
| Oct 7, 2026 | Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient ou… Serious | FDA Class II | |
| Oct 7, 2026 | a sterility problem Serious | FDA Class II | |
| Oct 7, 2026 | Defective Container; packets were found to be either empty or partially full. Serious | FDA Class II |
About this recall
Is Accord Healthcare Levothyroxine Sodium Tablets recalled?
Yes. Accord Healthcare, Inc. recalled it on August 6, 2026; FDA published it September 2, 2026 (Class II). Only the lots, dates or models listed on this page are included.
Why was it recalled?
Because of the wrong strength. The reason given: Subpotent Drug
What should I do if I have it?
Compare the recall numbers, lot numbers and expiration dates with what you have. Do not stop a prescribed medicine or device without talking to your pharmacist or doctor – they can arrange a replacement from an unaffected lot.
Where was it sold?
Nationwide.
More recalls
Source: recall records published by the U.S. Food and Drug Administration (openFDA Enforcement Reports), the USDA Food Safety and Inspection Service, the Consumer Product Safety Commission and the National Highway Traffic Safety Administration, collected twice a day. Product names, lot codes, dates and model numbers are shown exactly as the agency lists them; the agency's notice is the authority. 77.today is not affiliated with any of these agencies.